Tevis Investment Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.55M Sell
22,714
-303
-1% -$70.6K 3.16% 5
2025
Q4
$4.27M Hold
23,017
2.57% 11
2025
Q3
$4.27M Buy
23,017
+780
+4% +$134K 2.57% 11
2025
Q2
$3.4M Buy
22,237
+4,545
+26% +$699K 2.18% 13
2025
Q1
$2.56M Hold
17,692
1.9% 16
2024
Q4
$2.56M Buy
17,692
+358
+2% +$55.5K 1.9% 16
2024
Q3
$2.81M Buy
17,334
+884
+5% +$141K 2.08% 11
2024
Q2
$2.4M Buy
16,450
+3,895
+31% +$579K 1.93% 13
2024
Q1
$1.99M Buy
12,555
+1,327
+12% +$211K 1.69% 19
2023
Q4
$1.76M Buy
11,228
+2,537
+29% +$389K 1.62% 18
2023
Q3
$1.35M Buy
8,691
+32
+0.4% +$5.28K 1.37% 24
2023
Q2
$1.43M Buy
8,659
+191
+2% +$30.8K 1.4% 23
2023
Q1
$1.31M Buy
8,468
+1,691
+25% +$273K 1.33% 26
2022
Q4
$1.2M Sell
6,777
-27
-0.4% -$4.66K 1.28% 33
2022
Q3
$1.11M Buy
6,804
+63
+0.9% +$10.7K 1.08% 31
2022
Q2
$1.2M Buy
6,741
+38
+0.6% +$6.77K 1.15% 29
2022
Q1
$1.19M Buy
6,703
+100
+2% +$17K 1.08% 30
2021
Q4
$1.13M Buy
+6,603
New +$1.08M 0.99% 30

Other funds holding JNJ

Tevis Investment Management's JNJ Position: Q1 2026 in Review

Tevis Investment Management reduced its Johnson & Johnson (JNJ) stake by 1.3% in Q1 2026, selling an estimated $70.6K and leaving 22,714 shares worth $5.55M. The position accounts for 3.16% of the portfolio, ranked #5.

Tevis Investment Management first reported a position in JNJ in Q4 2021 and has held it in 18 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Tevis Investment Management held 22,714 shares of Johnson & Johnson worth $5.55M as of Q1 2026.
  • Tevis Investment Management sold 303 Johnson & Johnson shares in Q1 2026, an estimated $70.6K.
  • Johnson & Johnson made up 3.16% of Tevis Investment Management's portfolio in Q1 2026, its #5 holding.
  • Tevis Investment Management first reported a position in Johnson & Johnson in Q4 2021 and has held it in 18 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Tevis Investment Management's 13F filing for Q1 2026, filed 4 May 2026.